Skip to content
Search

Latest Stories

NPA diversifies board with appointment of 3 Women

NPA diversifies board with appointment of 3 Women

The decision to appoint these women aligns with the NPA's new values-led approach, emphasising equality, inclusion, and diversity within its leadership structure.

In a move towards greater diversity and inclusivity, the National Pharmacy Association (NPA) has welcomed three accomplished women to its board of key members. Aisling O’Brien, Sukhi Basra, and Sehar Shahid-who is the youngest member- have joined the board, marking a significant step in the organisation's commitment to equality and representation.


The announcement, made on the occasion of the International Women’s Day, by chief executive, Paul Rees MBE via X reflects the organisation's dedication to celebrating and empowering women in the pharmacy profession.

Sukhi Basra, who joined the board as member since last April, adds a valuable dimension to the NPA. With her role as a Community Pharmacy KCW committee member and her experience in clinical pharmacy spanning over 25 years, she brings a wealth of knowledge and a distinctive viewpoint.

Her unwavering commitment to championing community pharmacy and empowering female pharmacists resonates deeply with the organisation's core values and its forward-looking vision.

With her background in leadership and entrepreneurial roles within the pharmacy profession, Sehar Shahid offers invaluable insights and a passion for driving positive change. A qualified independent pharmacist prescriber, consultant, and the director of 24 HR Pharmacy, her commitment to fostering inclusion and empowering future generations of female leaders exemplifies the NPA's ethos of inspiring and supporting women in pharmacy.

Whereas, the latest member, Aisling O’Brien, director of O'Brien’s chemists Ltd, brings extensive experience and a deep understanding of community pharmacy to the board. With a career spanning 25 years and a proven track record of leadership within the pharmaceutical sector, Aisling's appointment reinforces the NPA's commitment to supporting women in leadership roles.

Speaking on the appointments, NPA Chair Nick Kaye expressed his delight in welcoming Aisling to the board, highlighting her expertise and dedication to the sector: “We are delighted to welcome Aisling to the NPA board. She brings with her bags of relevant experience and a passion for community pharmacy. I know she will be an effective advocate for the NPA and the sector at large.”

With these appointments, the NPA reinforces its position as a leading advocate for diversity, inclusion, and excellence within the pharmacy sector, setting a precedent for other organisations to follow suit in embracing representative leadership.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less